-
Novo Nordisk GLP-1 weight loss drug officially enters China, what is the pricing
On November 17th, Novo Nordisk announced that its glucagon like peptide-1 receptor agonist (GLP-1 RA) weekly formulation, semaglutide (trade name: Novo Nordisk), for long-term weight management, has ... -
Novo Nordisk's European stock fell 6.5%
On August 7th, Southern Finance and Economics reported that Novo Nordisk's European stock fell 6.5%. Novo Nordisk's Q2 net profit fell short of expectations, increasing only 3% year-on-year, and lowe ... -
The slimming elixir is on sale! Novo Nordisk raised its annual operating profit growth by at least 40%
On October 13th local time, the official website of Novo Nordisk (NVO.US) announced that based on a fixed exchange rate (CER), sales for the first nine months of 2023 increased by 33% year-on-year, a ... -
Novo Nordisk has once again raised its sales and operating profit expectations for 2023
On October 13th, Danish pharmaceutical company Novo Nordisk announced on its official website that based on a fixed exchange rate (CER), sales for the first nine months of 2023 increased by 33% year- ...